Medical use of 2-[4-(benzoxazole-2-oxyl)phenoxy] fatty acid pyridinamine
A technology of fatty acylpyridinamine and benzoxazole, which can be applied in the fields of drug combination, antineoplastic drugs, organic chemistry, etc., and can solve the problem that there is no research and development report on the anticancer activity of fatty acylpyridinamine
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0019] Preparation of N-(3-nitropyridin-2-yl)-2-[4-(6-chlorobenzoxazol-2-oxyl)phenoxy]propionamide
[0020] 2-[4-(6-Chlorobenzoxazole-2-oxyl)phenoxy]propionyl chloride (3.3mmol), dichloromethane (40mL), 2-amino-3-nitropyridine (3.3mmol) And catalytic amount of 4-dimethylaminopyridine (DMAP), stirred for 10min, added dropwise triethylamine (1.0g, 10mmol), refluxed for 7h, the reaction solution was poured into 150ml ice water, dichloromethane extracted, anhydrous sodium sulfate Drying, precipitating, column chromatography obtains N-(3-nitropyridin-2-yl)-2-[4-(6-chlorobenzoxazole-2-oxyl)phenoxy]propionamide, melting point 156.0~156.3℃; 1 H NMR (300MHz, CDCl 3 )δ: 1.74 (d, J=6.6Hz, 3H, CH 3 ), 4.90(q, J=6.6Hz, 1H, CH), 7.12~7.45(m, 8H, benzene ring-H, pyridine ring-H, benzoxazole-H), 8.53(dd, J 1 =8.1Hz,J 2 =1.2Hz, 1H, pyridine ring-H), 8.79(d, J=3.0Hz, 1H, benzoxazole-H), 11.20(s, 1H, NH); 13 C NMR (75MHz, CDCl 3 )δ: 18.45, 75.70, 110.64, 116.59, 119.19, 119.76, 121.63, 12...
Embodiment 2
[0022] Preparation of N-(pyridin-2-yl)-2-[4-(benzoxazole-2-oxyl)phenoxy]fatty acid amide (I)
[0023]
[0024] where R, R 1 Selected from: Hydrogen, Deuterium, C 1 ~C 2 Alkyl, C 3 ~C 4 Straight chain or branched chain alkyl; X 1 、X 2 、X 4 、X 5 、X 6 、X 7 、X 8 、X 10 selected from: hydrogen, deuterium or C 1 ~C 2 Alkyl; X 3 is selected from: fluorine, chlorine, bromine; X 3 From: Nitro; X 9 is selected from: fluorine, chlorine, bromine.
[0025] N-(pyridin-2-yl)-2-[4-(benzoxazole-2-oxyl)phenoxy]fatty acid amide (I) was prepared according to the method in Example 1.
Embodiment 3
[0027] Preparation of N-(pyridin-2-yl)-2-[4-(benzoxazole-2-oxyl)phenoxy]fatty acid amide (Ⅱ)
[0028]
[0029] where R, R 1 Selected from: Hydrogen, Deuterium, C 1 ~C 2 Alkyl, C 3 ~C 4 Straight chain or branched chain alkyl; X 1 、X 2 、X 4 、X 5 、X 6 、X 7 、X 8 、X 10 selected from: hydrogen, deuterium or C 1 ~C 2 Alkyl; X 3 is selected from: fluorine, chlorine, bromine; X 3 From: Nitro; X 9 is selected from: fluorine, chlorine, bromine.
[0030]N-(pyridin-2-yl)-2-[4-(benzoxazol-2-oxyl)phenoxy]fatty acid amide (II) was prepared according to the method in Example 1.
PUM
| Property | Measurement | Unit |
|---|---|---|
| wavelength | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
Login to View More - R&D
- Intellectual Property
- Life Sciences
- Materials
- Tech Scout
- Unparalleled Data Quality
- Higher Quality Content
- 60% Fewer Hallucinations
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2025 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com

![Medical use of 2-[4-(benzoxazole-2-oxyl)phenoxy] fatty acid pyridinamine](https://images-eureka.patsnap.com/patent_img/7384321c-f80d-444e-89b0-983c03775da0/BDA0000506126810000011.png)
![Medical use of 2-[4-(benzoxazole-2-oxyl)phenoxy] fatty acid pyridinamine](https://images-eureka.patsnap.com/patent_img/7384321c-f80d-444e-89b0-983c03775da0/BDA0000506126810000021.png)
![Medical use of 2-[4-(benzoxazole-2-oxyl)phenoxy] fatty acid pyridinamine](https://images-eureka.patsnap.com/patent_img/7384321c-f80d-444e-89b0-983c03775da0/BDA0000506126810000022.png)